1. |
Tan TE, Wong TY. Diabetic retinopathy: looking forward to 2030[J/OL]. Front Endocrinol (Lausanne), 2022, 13: 1077669[2023-01-09]. https://pubmed.ncbi.nlm.nih.gov/36699020/. DOI: 10.3389/fendo.2022.1077669.
|
2. |
Kang Q, Dai H, Jiang S, et al. Advanced glycation end products in diabetic retinopathy and phytochemical therapy[J/OL]. Front Nutr, 2022, 9: 1037186[2022-11-18]. https://pubmed.ncbi.nlm.nih.gov/36466410/. DOI: 10.3389/fnut.2022.1037186.
|
3. |
夏黎黎. 人体晚期糖基化终末产物三种测定方法的比较性研究[D]. 武汉: 华中科技大学, 2021.Xia LL. Comparative study of three measurement methods for human advanced glycation end-products[D]. Wuhan: Huazhong University of Science and Technology, 2021.
|
4. |
中国医师协会内分泌代谢科医师分会, 国家代谢性疾病临床医学研究中心. 糖尿病分型诊断中国专家共识[J]. 中华糖尿病杂志, 2022, 14(2): 120-139. DOI: 10.3760/cma.j.cn115791-20211219-00672.Chinese Endocrinologist Association, Chinese Medical Doctor Association, National Clinical Research Center for Metabolic Diseases. Classification of diabetes mellitus in China: an expert consensus statement[J]. Chin J Diabetes Mellitus, 2022, 14(2): 120-139. DOI: 10.3760/cma.j.cn115791-20211219-00672.
|
5. |
中华医学会眼科学分会眼底病学组, 中国医师协会眼科医师分会眼底病学组. 我国糖尿病视网膜病变临床诊疗指南(2022年)——基于循证医学修订[J]. 中华眼底病杂志, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.Fundus Disease group of Ophthalmological Society of Chinese Medical Association, Fundus Disease group of Ophthalmologist Branch of Chinese Medical Doctor Association. Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)[J]. Chin J Ocul Fundus Dis, 2023, 39(2): 99-124. DOI: 10.3760/cma.j.cn511434-20230110-00018.
|
6. |
Wilkinson CP, Ferris FR, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J]. Ophthalmology, 2003, 110(9): 1677-1682. DOI: 10.1016/S0161-6420(03)00475-5.
|
7. |
沈艳玲, 张云波, 刘承红, 等. 晚期糖基化终末产物在衰老相关疾病中的研究进展[J]. 国际老年医学杂志, 2024, 45(4): 486-489. DOI: 10.3969/j.issn.1674-7593.2024.04.019.Shen YL, Zhang YB, Liu CH, et al. Research progress on advanced glycation end products in aging-related diseases[J]. Int J Geriatr, 2024, 45(4): 486-489. DOI: 10.3969/j.issn.1674-7593.2024.04.019.
|
8. |
Lin KY, Hsih WH, Lin YB, et al. Update in the epidemiology, risk factors, screening, and treatment of diabetic retinopathy[J/OL]. J Diabetes Investig, 2021, 12(8): 1322-1325[2021-01-14]. https://pubmed.ncbi.nlm.nih.gov/33316144/. DOI: 10.1111/jdi.13480.
|
9. |
Xu J, Chen LJ, Yu J, et al. Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy[J]. Cell Physiol Biochem, 2018, 48(2): 705-717. DOI: 10.1159/000491897.
|
10. |
Oshitari T. Advanced glycation end-products and diabetic neuropathy of the retina[J/OL]. Int J Mol Sci, 2023, 24(3): 2927[2023-02-02]. https://pubmed.ncbi.nlm.nih.gov/36769249/. DOI: 10.3390/ijms24032927.
|
11. |
杨彩霞, 夏利. 血清晚期糖基化终末产物和血管内皮生长因子水平与2型糖尿病患者视网膜病变的关系[J]. 中华实用诊断与治疗杂志, 2023, 37(7): 711-715. DOI: 10.13507/j.issn.1674-3474.2023.07.013.Yang CX, Xia L. Correlations of serum advanced glycation end products and vascular endothelial growth factor with retinopathy in patients with type 2 diabetic mellitus[J]. J Chin Pract Diagn Ther, 2023, 37(7): 711-715. DOI: 10.13507/j.issn.1674-3474.2023.07.013.
|
12. |
王卓实, 张倩茹, 朱平利, 等. 晶状体内糖基化终末产物含量与糖尿病视网膜病变程度的关联分析[J]. 中华实验眼科杂志, 2017, 35(11): 1030-1034. DOI: 10.3760/cma.j.issn.2095-0160.2017.11.015.Wang ZS, Zhang QR, Zhu PL, et al. Association analysis of advanced glycation end-products in lens with diabetic retinopathy severity[J]. Chin J Exp Ophthalmol, 2017, 35(11): 1030-1034. DOI: 10.3760/cma.j.issn.2095-0160.2017.11.015.
|
13. |
朱灵, 王贻坤, 叶山东, 等. 基于皮肤自体荧光的糖尿病快速无创筛查方法的临床研究[J]. 中华糖尿病杂志, 2013, 5(5): 293-296. DOI: 10.3760/cma.j.issn.1674-5809.2013.05.010.Zhu L, Wang YK, Ye SD, et al. Investigation on noninvasive and rapid diabetes screening using skin autofluorescence[J]. Chin J Diabetes Mellitus, 2013, 5(5): 293-296. DOI: 10.3760/cma.j.issn.1674-5809.2013.05.010.
|
14. |
Meerwaldt R, Graaff R, Oomen P, et al. Simple non-invasive assessment of advanced glycation endproduct accumulation[J]. Diabetologia, 2004, 47(7): 1324-1330. DOI: 10.1007/s00125-004-1451-2.
|
15. |
叶成松, 叶山东, 王贻坤, 等. 皮肤AGEs检测和血清AGEs测定相关性研究[J]. 中国实验诊断学, 2014(11): 1768-1770.Ye CS, Ye SD, Wang YK, et al. Correlation between skin advanced glycation end products and serum advanced glycation end products[J]. Chin J Lab Diagn, 2014(11): 1768-1770.
|
16. |
杨三梅, 余锋, 王贻坤, 等. 晚期糖基化终末产物荧光光谱检测法在糖尿病筛查中的应用研究[J]. 激光生物学报, 2011, 20(1): 116-119,129. DOI: 10.3969/j.issn.1007-7146.2011.01.022.Yang SM, Yu F, Wang YK, et al. Study on the application of fluorescence spectrum of advanced glycation end products to diagnosis of diabetes mellitus[J]. Acta Laser Biology Sinica, 2011, 20(1): 116-119,129. DOI: 10.3969/j.issn.1007-7146.2011.01.022.
|
17. |
叶山东, 章秋, 王长江, 等. 皮肤糖基化终产物无创检测筛查2型糖尿病的临床应用[J]. 中国糖尿病杂志, 2017, 25(9): 827-830. DOI: 10.3969/j.issn.1006-6187.2017.09.013.Ye SD, Zhang Q, Wang CJ, et al. Clinical application of non-invasive detection of skin advanced glycation end products in type 2 diabetes[J]. Chin J Diabetes, 2017, 25(9): 827-830. DOI: 10.3969/j.issn.1006-6187.2017.09.013.
|
18. |
Ying L, Shen Y, Zhang Y, et al. Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus[J/OL]. Diabetes Res Clin Pract, 2021, 177: 108880[2021-05-29]. https://pubmed.ncbi.nlm.nih.gov/34058298/. DOI: 10.1016/j.diabres.2021.108880.
|
19. |
Duan J, Liu D, Zhao Z, et al. Short-term duration of diabetic retinopathy as a predictor for development of diabetic kidney disease[J]. J Transl Int Med, 2023, 11(4): 449-458. DOI: 10.2478/jtim-2022-0074.
|
20. |
Yin L, Zhang D, Ren Q, et al. Prevalence and risk factors of diabetic retinopathy in diabetic patients: a community based cross-sectional study[J/OL]. Medicine (Baltimore), 2020, 99(9): e19236[2020-02-01]. https://pubmed.ncbi.nlm.nih.gov/32118727/. DOI: 10.1097/MD.0000000000019236.
|